REPL
Replimune Group Inc
13.10$
+1.6%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | |
| – | +0.0% | -6.4% | +12.4% | +22.3% | +11.1% | -15.2% | +96.3% | -1.5% | +0.5% | – | – | – | |
| – | – | – | -121.7% | – | – | – | – | – | – | – | – | – | |
| – | -12.7% | -0.6% | +0.9% | +1.1% | +10.5% | +13.6% | +6.1% | +0.1% | -8.2% | -1.5% | -5.8% | – | |
| – | -7.0% | +18.1% | -11.0% | +7.5% | +16.5% | +40.7% | +28.5% | -18.9% | -29.1% | +12.2% | -9.7% | – | |
| – | -11.4% | +3.9% | -2.4% | +2.7% | +12.1% | +19.7% | +14.4% | -6.8% | -14.7% | +2.0% | -6.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.7% | +25.7% | +0.5% | +0.5% | +0.5% | +0.4% | +0.6% | -74.0% | +282.2% | +120.5% | -40.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -113.7% | – | – | – | -214.4% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.